CV Sciences (CVSI) Other Non-Current Liabilities (2015 - 2024)

CV Sciences (CVSI) reported Other Non-Current Liabilities of $38000.0 for Q3 2024, down 60.0% sequentially from $95000.0 in Q2 2024.

CV Sciences (CVSI) Other Non-Current Liabilities (2015 - 2024) Analysis & Trends

CV Sciences (CVSI) has 6 years of Other Non-Current Liabilities data on file, last reported at $38000.0 in Q3 2024.

  • For the quarter ending Q3 2024, Other Non-Current Liabilities changed N/A year-over-year to $38000.0; the trailing twelve-month figure through Sep 2024 stood at $38000.0 (changed N/A YoY), and the FY2023 full-year result was $105000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities fell to $38000.0 in Q3 2024, from $95000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $171000.0 in Q1 2020 to a low of $38000.0 in Q3 2024.
  • A 3-year average of $102400.0 and a median of $103000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • Peak annual rise in Other Non-Current Liabilities reached 60.87% in 2020, while the deepest fall reached 60.87% in 2020.
  • Tracing CVSI's Other Non-Current Liabilities over 3 years: stood at $171000.0 in 2020, then tumbled by 38.6% to $105000.0 in 2023, then tumbled by 63.81% to $38000.0 in 2024.
  • Business Quant data shows CVSI's Other Non-Current Liabilities at $38000.0 in Q3 2024, $95000.0 in Q2 2024, and $103000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 38,000.00
Jun 30, 2024 95,000.00
Mar 31, 2024 103,000.00
Dec 31, 2023 105,000.00
Mar 31, 2020 171,000.00
Dec 31, 2019 406,000.00
Sep 30, 2019 298,000.00
Jun 30, 2019 406,000.00
Mar 31, 2019 437,000.00
Dec 31, 2017 29,300.00
Jun 30, 2017 29,300.00
Mar 31, 2017 29,300.00
Dec 31, 2015 250,000.00